{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038005","form_type":"8-K","ticker":"CELC","cik":"0001603454","company_name":"Celcuity Inc.","filed_at":"2023-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.737980+00:00","generated_at":"2026-06-09T16:43:43.054182+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Celcuity raises $50M via private placement of pre-funded warrants","bullets":["Gross proceeds of ~$50M from sale of pre-funded warrants to institutional investor.","Warrants purchase up to 5,747,787 shares at $8.70 each, exercise price $0.001/share.","Net proceeds to advance clinical development of gedatolisib and for general corporate purposes.","Warrants immediately exercisable; resale registration statement to be filed within 30 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038005","json":"https://secwatch.observer/filing/0001493152-23-038005.json","markdown":"https://secwatch.observer/filing/0001493152-23-038005.md","text":"https://secwatch.observer/filing/0001493152-23-038005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603454/000149315223038005/0001493152-23-038005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603454/000149315223038005/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T16:43:43.054182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9e4d96d266dc30e53f5f407d316d079f5f26ce99","claim":"Celcuity Inc. entered into Registration Rights Agreement with the Investors (effective 2023-10-18).","evidence_excerpt":"On October 18, 2023, in connection with the Securities Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Investors, pursuant to which the Company agreed to register for resale the (i) Warrant Shares then issued or issuable upon exercise of the Warrants","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1603454/000149315223038005/0001493152-23-038005-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the Investors"},{"label":"Effective","value":"2023-10-18"}],"fact_type":"material_agreement"},{"claim_id":"aed176f642f1a5361a614c4fbd0b9430ee01d8fe","claim":"Celcuity Inc. entered into Securities Purchase Agreement with certain investors valued at approximately $50 million (effective 2023-10-18).","evidence_excerpt":"On October 18, 2023, Celcuity Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the Company agreed to sell to the Investors in a private placement (the “Private Placement”) pre-funded warrants (the “Warrants”) to purchase up to 5,747,787 shares of the Company’s common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1603454/000149315223038005/0001493152-23-038005-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors"},{"label":"Value","value":"approximately $50 million"},{"label":"Effective","value":"2023-10-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}